Table 3.
Demographic and clinical characteristics of the final study sample.
| Characteristic | n (total = 128) | Percentage (%) |
|---|---|---|
| Age (years) | ||
| Mean (SD) | 57.4 | (14.7) |
| 18–44 | 28 | 21.9 |
| 45–64 | 55 | 43.0 |
| ≥65 | 44 | 34.4 |
| Missing | 1 | 0.8 |
| Gender | ||
| Male | 48 | 37.5 |
| Female | 80 | 62.5 |
| Race/ethnicity | ||
| Non-Hispanic White | 77 | 60.2 |
| Hispanic or Latino | 34 | 26.6 |
| Native American | 2 | 1.6 |
| African-American | 6 | 4.7 |
| Asian | 2 | 1.6 |
| Two or more races | 6 | 4.7 |
| Missing | 1 | 0.8 |
| Annual household income | ||
| <US$20,000 | 26 | 20.3 |
| $20,000–835,000 | 30 | 23.4 |
| $35,001-$50,000 | 22 | 17.2 |
| $50,001–875,000 | 23 | 18.0 |
| >$75,000 | 27 | 21.1 |
| Education | ||
| Less than high school | 3 | 2.3 |
| High school graduate | 22 | 17.2 |
| Some college | 36 | 28.1 |
| College graduate | 46 | 35.9 |
| Graduate school | 21 | 16.4 |
| Marital status | ||
| Single | 33 | 25.8 |
| Married | 51 | 39.8 |
| Widowed | 20 | 15.6 |
| Divorced/separated | 24 | 18.8 |
| Health insurance | ||
| Yes | 126 | 98.4 |
| No | 2 | 1.6 |
| Number of chronic diseases | ||
| Mean (SD) | 3.8 | (1.8) |
| 1–3 | 61 | 47.7 |
| ≥4 | 67 | 52.3 |
| Number of prescription meds | ||
| Mean (SD) | 5.8 | (2.8) |
| 1–4 | 40 | 31.3 |
| 5–10 | 79 | 61.7 |
| ≥11 | 9 | 7.0 |
| Cancer | ||
| Yes | 13 | 10.2 |
| No | 115 | 89.8 |
| Overall attitude toward PGx testing | ||
| Yes | 113 | 88.3 |
| No | 14 | 10.9 |
| Missing | 1 | 0.8 |
| Previous PGx experience | ||
| Yes | 2 | 1.6 |
| No | 125 | 97.6 |
| Missing | 1 | 0.8 |
PGx: Pharmacogenomics; SD: Standard deviation.